Naluzotan is primarily investigated for its potential therapeutic applications in the field of neurology, particularly in the treatment of anxiety and depression. It functions as a serotonin receptor agonist, specifically targeting the 5-HT1A receptor, which plays a significant role in mood regulation. By modulating this receptor, it may help alleviate symptoms associated with mood disorders. Research has also explored its neuroprotective properties, suggesting it could be beneficial in conditions involving neuronal damage or degeneration. Clinical studies have focused on its efficacy and safety profile, aiming to establish its role as a viable treatment option for mental health disorders.